A
Amy Kunchok
Researcher at Mayo Clinic
Publications - 44
Citations - 909
Amy Kunchok is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Medicine & Myelin oligodendrocyte glycoprotein. The author has an hindex of 10, co-authored 23 publications receiving 360 citations. Previous affiliations of Amy Kunchok include University of Melbourne & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
A multicenter comparison of MOG-IgG cell-based assays
Patrick Waters,Lars Komorowski,M Woodhall,Sabine Lederer,Masoud Majed,J. P. Fryer,John Mills,Eoin P. Flanagan,Sarosh R. Irani,Amy Kunchok,Andrew McKeon,Sean J. Pittock +11 more
TL;DR: A high degree of agreement was observed across 3 different MOG-IgG CBAs from 3 international centers, indicating that positive results in these assays are more reliable indicators of MOG autoimmune spectrum disorders.
Journal ArticleDOI
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.
John J. Chen,Eoin P. Flanagan,M. Tariq Bhatti,Jiraporn Jitprapaikulsan,Divyanshu Dubey,Alfonso S Lopez Chiriboga,James P. Fryer,Brian G. Weinshenker,Andrew McKeon,Jan Mendelt Tillema,Vanda A. Lennon,Claudia F. Lucchinetti,Amy Kunchok,Collin M. McClelland,Michael S. Lee,Jeffrey Bennett,Victoria S. Pelak,Gregory P. Van Stavern,Ore-Ofe O Adesina,Eric R. Eggenberger,Marie D. Acierno,Dean M. Wingerchuk,Byron L. Lam,Heather E. Moss,Shannon Beres,Aubrey L. Gilbert,Veeral Shah,Grayson W. Armstrong,Gena Heidary,Dean M. Cestari,Hadas Stiebel-Kalish,Sean J. Pittock +31 more
TL;DR: This large retrospective multicenter study of patients with MOGAD suggests that maintenance immunotherapy reduces recurrent CNS demyelinating attacks, with the lowest ARR being associated with maintenance IVIG therapy.
Journal ArticleDOI
Autoimmune glial fibrillary acidic protein astrocytopathy
TL;DR: Autoimmune GFAP astrocytopathy is a treatable autoimmune CNS disease diagnosable by GFAP-IgG testing in CSF, and presents opportunities to explore novel mechanisms of CNS autoimmunity and inflammation.
Journal ArticleDOI
Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events.
Amy Kunchok,Allen J. Aksamit,John M. Davis,Orhun H. Kantarci,B. Mark Keegan,Sean J. Pittock,Brian G. Weinshenker,Andrew McKeon +7 more
TL;DR: This case-control study examines the inflammatory CNS event outcome among patients with an autoimmune disease who were treated with tumor necrosis factor inhibitors.
Journal ArticleDOI
Comparison of MRI lesion evolution in different central nervous system demyelinating disorders
Elia Sechi,Elia Sechi,Karl N. Krecke,Steven A. Messina,Marina Buciuc,Sean J. Pittock,John J. Chen,Brian G. Weinshenker,A. Sebastian Lopez-Chiriboga,Claudia F. Lucchinetti,Nicholas L. Zalewski,Jan Mendelt Tillema,Amy Kunchok,Salvatore Monaco,Padraig P. Morris,James P. Fryer,Adam Nguyen,Tammy M. Greenwood,Stephanie B. Syc-Mazurek,B. Mark Keegan,Eoin P. Flanagan +20 more
TL;DR: In this paper, the authors compare MRI T2 lesion evolution in myelin oligodendrocyte glycoprotein immunoglobulin G (IgG)-associated disorder (MOGAD), aquaporin 4 IgG-positive neuromyelitis optica spectrum disorder (AQP4-Igg-NMOSD), and multiple sclerosis (MS).